Print this page
-
A Phase II Randomized Pilot Study Comparing High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy in Localized Prostate Cancer.
Protocol: 081805Principal Investigator:
- Lara Hathout MD (Rutgers University)
Applicable Disease Sites: Prostate -
The Role of Adaptive Radiation Planning in Patients with Non-Small Cell Lung Cancer on Radiation Induced Toxicity .
Protocol: 032009Principal Investigator:
- Salma Jabbour M.D. (Rutgers University)
Applicable Disease Sites: Lung -
A Phase I Study to Evaluate the Safety of Colchicine for Treatment and Prevention of Radiation-Induced Dermatitis.
Protocol: 032112Principal Investigator:
- Bruce Haffty MD (Rutgers University)
Applicable Disease Sites: Lip, Oral Cavity and Pharynx -
Preoperative ChemoRadiation and FOLFOXIRI To Escalate Complete Response for Rectal Cancer.
Protocol: 072202Principal Investigator:
- Salma Jabbour M.D. (Rutgers University)
Applicable Disease Sites: Rectum -
A Phase II Study of Preoperative Pembrolizumab for Mismatch Repair Deficient, Epstein-Barr Virus Positive and/or PD-L1 Positive Gastric Cancer followed by Chemotherapy and Chemoradiation with Pembrolizumab.
Protocol: 071702Principal Investigator:
- Salma Jabbour M.D. (Rutgers University)
Applicable Disease Sites: Stomach -
Phase II Trial of Radium-223 Dichloride in Combination with Paclitaxel in Patients with Bone Metastatic Breast Cancer.
Protocol: 052001Principal Investigator:
- Salma Jabbour M.D. (Rutgers University)
Applicable Disease Sites: Breast